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Introduction: The objective of this study was to examine the racial disparities in total ankle arthroplasty (TAA)
utilization and outcomes.
Methods: We used the National Inpatient Sample (NIS) to study the time-trends. Race was categorized as White
and Black. Utilization rates were calculated for the U.S. general population per 100,000. Hospital length of stay,
discharge disposition and mortality after TAA were assessed. We used the Cochran Armitage trend test to assess
time-trends from 1998 to 2011 and chi-square test to compare TAA utilization. We used analysis of variance or
chi-squared test to compare the characteristics of Whites and Blacks undergoing TAA and logistic regression to
compare mortality, length of stay and discharge to home versus medical facility.
Results: The mean ages for Whites undergoing TAA were 62 years and for Blacks was 52 years. Significant racial
disparities were noted in TAA utilization rates (/100,000) in 1998, 0.14 in Whites vs. 0.07 in Blacks (P < 0.0001; 2-fold) and
in 2011, 1.17 in Whites vs. 0.33 in Blacks (P < 0.0001; 4-fold). Racial disparities in TAA utilization increased significantly
from 1998 to 2011 (P < 0.0001). There was a trend towards statistical significance for the difference in the length of
hospital stay in Blacks vs. Whites (52.9% vs. 44.3% with length of hospital stay higher than the median; P = 0.08).
Differences in the proportion discharged to an inpatient medical facility after TAA, 16.6% Blacks vs. 13.4% Whites, were
not significant (P = 0.36).
Conclusions: This study demonstrated significant racial disparities with lower TAA utilization and suboptimal outcomes
in Blacks compared to Whites. Further studies are needed to understand the mediators of these disparities and to
assess whether these mediators can be targeted to reduce racial disparities in TAA.Introduction
Racial and ethnic disparities are widespread in health care
[1-5]. The 2002 Institute of Medicine report called for
‘Confronting Racial and Ethnic Disparities in Health Care’
[6]. The 2009 Institute of Medicine’s comparative effect-
iveness research agenda included reduction in racial dis-
parities in the first quartile of the 100 top priority areas
[7]. Unless all segments of the population receive optimal
health care, best health care outcomes cannot be realized
for the population as a whole. Racial disparities in arthro-
plasty are of great interest, due to several reasons. Lower* Correspondence: jassingh@uab.edu
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article, unless otherwise stated.extremity osteoarthritis (OA), the most common reason
for arthroplasty, has similar or higher prevalence in Blacks
compared with Whites [8]. OA is more severe and more
symptomatic in Blacks than Whites [9-13]. Arthroplasty, a
definitive surgical treatment for end-stage OA (and other
types of arthritis), is associated with significant improve-
ments in quality of life and functional ability [14,15]; and
there is no evidence that benefits of arthroplasty are lower
in Blacks, compared with Whites. This implies that the
need for arthroplasty is at least as great or greater in Blacks,
when compared with Whites. Additionally, the benefits of
arthroplasty do not seem to differ by race to justify a lower
utilization in Blacks compared with Whites. However, nu-
merous studies have shown that the utilization of knee or
hip arthroplasty is much lower in Blacks than Whites
[16-19]. This indicates that Blacks with end-stage arthritis
are not experiencing the arthroplasty-associated quality-of-
life improvements to the same extent as Whites. Moreomed Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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reasons for racial disparities in arthroplasty utilization.
Arthroplasty involves replacing diseased joint surfaces
with plastic or metal components to relieve pain and im-
prove joint function and mobility. Hip and knee joints are
the most common lower extremity arthroplasty surgeries
performed for end-stage arthritis. Another lower extremity
joint affected not uncommonly is the ankle joint. Ankle
joint arthritis can lead to disabling pain and functional
limitation [20]. Total ankle arthroplasty (TAA) is the surgi-
cal treatment for end-stage ankle joint disease [21,22], an
alternative to ankle arthrodesis [23]. The increasing use of
TAA is due to much better clinical and radiographic out-
comes with the second-generation and third-generation
prostheses compared with the earlier designs [24,25].
In a recent study, we found an increase in TAA
utilization in the United States from 1998 to 2011 [26].
As the utilization of TAA increases, an important ques-
tion is whether the racial disparities described for knee
and hip arthroplasty exist for TAA. To our knowledge,
no studies have assessed racial disparities in TAA
utilization and outcomes. Our study objectives were to
assess racial disparities in TAA utilization and outcomes.
We asked whether there are any racial disparities in
utilization of TAA, whether utilization disparities be-
tween Blacks and Whites are decreasing over time, and
whether the outcomes of TAA differ by race.
Methods
Data source
We used the National Inpatient Sample (NIS; previously
called Nationwide Inpatient Sample) data from 1998 to
2011 for this study. The NIS is the largest inpatient care
database that provides data on hospital inpatient stays for
all patients in the United States, and is publicly available.
The NIS contains data from approximately 8 million hos-
pital stays each year. The US NIS contains approximately a
20% stratified sample of US community hospitals; in 2011,
46 states provided data [27]. The NIS includes all patients
regardless of the payer. In other words, the NIS includes
patients covered by Medicare, Medicaid, private insurance
and the uninsured. Since the NIS has a representative sam-
ple, it has been used to analyze national trends in outcomes
of various conditions during the inpatient stay [28,29]. The
NIS can be weighted to obtain national estimates. The NIS
contains primary and secondary diagnoses, patient demo-
graphics, length of stay, admission and discharge status,
hospital characteristics and total charges. For each
hospital admission, the International Classification of Dis-
eases Ninth Revision Common Modification (ICD-9-CM)
diagnostic and procedure information are available. The
Institutional Review Board at the University of Alabama at
Birmingham approved the study. No patient consent was
needed, since these data are de-identified.Study cohort, time periods, main predictor and covariates
The study cohort consisted of patients who underwent a
primary TAA, identified by the presence of ICD-9-CM
procedure code 81.56 during the hospitalization, from
1998 to 2011. We divided the calendar years into 2-year
to 3-year intervals a priori (1998 to 2000, 2001 to 2002,
2003 to 2004, 2005 to 2006, 2007 to 2008 and 2009 to
2011), in order to have an adequate number of cases for
analyses for mortality, discharge status and length of
hospital stay (since the groups with smaller numbers,
Black males and Black females, had few or no patients
with outcomes in some years).
Race, the main independent variable of interest, was
categorized as White and Black. We included covariates
previously shown or suspected to be associated with
arthroplasty utilization and/or outcomes [30-35]. Patient
demographic (age, sex) and clinical characteristics
(underlying diagnosis, comorbidity) were obtained. We
categorized age into <50 years, 50 to <65 years, 65 to
<80 years and ≥80 years, and the underlying diagnosis
into OA, rheumatoid arthritis, avascular necrosis of the
bone, fracture and other (post-traumatic arthritis, septic
arthritis, Charcot joint, and so forth). Comorbidity was
assessed using the validated Deyo-Charlson index [26], a
sum of 17 comorbidities [27,28] at the index admission
preoperatively, based on the presence of ICD-9-CM
codes. The Deyo-Charlson index was categorized as 0, 1
or 2 or more.Study outcomes
The TAA utilization rates for Whites and Blacks were
calculated by dividing the respective NIS estimates by
the total US population for Whites/Blacks for the re-
spective year obtained from the US census site, ex-
pressed per 100,000 patients [36]. Hospital length of stay
was calculated as the number of days from admission to
discharge for the index TAA admission. Mortality re-
lated to the index admission was assessed using the mor-
tality during the index hospital admission. Discharge
status was categorized as discharge: home with or with-
out home health care; or to an inpatient facility that in-
cluded a short-term hospital, a skilled nursing facility, an
intermediate care facility or another type of inpatient fa-
cility. We excluded patients who died in the hospital or
left the hospital against medical advice from the analyses
of utilization and discharge outcomes only. Outcomes
(hospital stay, discharge disposition and mortality) were
calculated for categories of 2 or 3 years for time-trend
analyses. We categorized the annual hospital volumes
for TAA as <5 procedures/year, 5 to 9 procedures/year,
10 to 14 procedures/year, 15 to 24 procedures/year
and ≥25 procedures/year. Length of stay was categorized
into greater than the median or less than the median.
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We calculated 95% confidence intervals for utilization
rates based on binomial proportions. We applied data
weights as recommended to obtain weighted estimates
[37]. We used the Cochran Armitage trend test to assess
time trends from 1998 to 2011 and the chi-square test to
compare TAA utilization between 1988 and 2011. Analysis
of variance or the chi-squared test was used to compare
the characteristics of Whites and Blacks undergoing TAA.
Logistic regression was used to compare mortality, length
of stay and discharge to home versus medical facility.
Results
Patient characteristics
In total, 12,122 Whites and 488 Blacks underwent TAA
during the study period. The mean ages for the Whites
and Blacks were 61.9 and 52.0 years, respectively;
55% and 62% were female, respectively (Table 1). The
underlying diagnosis was OA in 62.5% of Whites andTable 1 Characteristics of patients undergoing total ankle
arthroplasty, 1998 to 2011
White Black P value
(n = 12,122) (n = 488)
Age (years) 61.9 (61.1, 62.7) 52.0 (49.6, 54.3) <0.0001
Female 54.8 61.9 0.19
Age group
< 50 years 15.5 42.2 <0.0001
50 to 64 years 38.3 43.6 0.28
65 to 79 years 41.2 12.5 <0.0001
≥ 80 years 5.1 1.7 0.11
Underlying diagnosis
Osteoarthritis 62.5 47.2 0.005
Rheumatoid arthritis 5.6 10.3 0.04
Fracture 0.1 1.0 0.04
Traumatic arthropathy 18.8 18.6 0.96
Avascular necrosis 0.5 0.9 0.51
Other 12.6 22.0 0.01
Deyo-Charlson score
0 71.8 65.8 0.25
1 23.2 22.9 0.96
≥ 2 5.0 11.2 0.01
Hospital volume
(procedures/year)
< 5 35.2 47.6 0.04
5 to 9 25.6 26.5 0.89
10 to 14 12.3 5.7 0.14
15 to 24 17.7 14.4 0.42
≥ 25 9.3 5.8 0.21
Data presented as mean (95% confidence interval) or percentage.47.2% of Blacks. A total 5% of Whites and 11.2% of
Blacks had a Deyo-Charlson index ≥2 (Table 1). A sig-
nificantly higher proportion of Blacks (47.6%) than
Whites (35.2%; P = 0.04) underwent TAA at a hospital
with an annual volume <5 TAA procedures (Table 1).
Time trends in TAA utilization by race
We compared the time trends in TAA utilization by race.
TAA utilization was significantly higher in Whites than
Blacks in 1998, 0.14 versus 0.07 per 100,000 (P <0.0001;
twofold rate) (Table 2 and Figure 1). In 2011, TAA
utilization was 1.17 in Whites and 0.33 in Blacks, showing
significant racial disparities (P <0.0001; 3.5-fold rate). Dis-
parities in TAA utilization by race increased statistically
significantly from 1998 to 2011 (P <0.0001). The twofold
higher rate in Whites compared with Blacks in 1998 in-
creased to an almost fourfold higher rate in 2011 (Table 2
and Figure 1). The absolute White–Black difference in
TAA utilization rate was 0.07 per 100,000 in 1998 and
0.84 per 100,000 in 2011 (a 12-fold higher difference).
In further analyses of Whites and Blacks by sex, we
found that the utilization rates differed significantly be-
tween the groups in 1998 and 2011, numerically slightly
higher in females than males (Table 3). In addition, the
rates increased significantly from 1998 to 2011 in White
males (P <0.0001), White females (P <0.0001), Black
males (P = 0.0031) and Black females (P <0.0001).
A significant increase in TAA utilization over time
(1998 to 2011) was seen for all four age groups inTable 2 Time trends in annual total ankle arthroplasty
utilization by race
Year White Black P value
1998 0.14 0.07 <0.0001
1999 0.32 0.04 <0.0001
2000 0.29 0.07 <0.0001
2001 0.52 0.01 <0.0001
2002 0.35 0.13 <0.0001
2003 0.33 0.08 <0.0001
2004 0.40 0.06 <0.0001
2005 0.25 0.07 <0.0001
2006 0.18 0.05 <0.0001
2007 0.26 0.05 <0.0001
2008 0.47 0.10 <0.0001
2009 0.58 0.18 <0.0001
2010 0.90 0.09 <0.0001
2011 1.17 0.33 <0.0001
Total ankle arthroplasty utilization rates increased from 1998 to 2011: White,
P <0.0001; Black, P <0.0001 (Cochran Armitage trend test for time trends).
White–Black disparity was significantly more in 2011 compared with 1998:
P <0.0001.
Figure 1 Total ankle arthroplasty utilization rates per 100,000 in Whites and Blacks over time.
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P < 0.0001 for all others; Figure 2). When comparing
1998 with 2011, TAA utilization increased significantly
for all age groups (P <0.0001). In Blacks, no significant
time-related increase in TAA utilization rates was seen
in the <50 or 50 to 64 age categories (P = 0.07 and
0.053) and slight increases in the 65 to 79 and ≥80 age
groups (P = 0.009 and 0.0002; Figure 2). Additional file 1
shows these time trends in utilization by race in more
detail. Over time, we noted an increase in age and co-
morbidity, and change in the underlying diagnosis.
Outcomes variation by race
The proportion of Black patients with hospital stay
longer than the median stay was higher than WhiteTable 3 Time trends in total ankle arthroplasty utilization rat















N/A, not applicable since a frequency of 0 for at least one category did not allow ca
performed in that group in that calendar year. Cochran Armitage trend test for time
White females, P <0.0001; and Black females, P <0.0001. The p-value in the table inpatients (52.9% vs. 44.3%), with a trend towards signifi-
cance (P = 0.08; Table 4). A slightly higher proportion
of Blacks compared with Whites were discharged to an
inpatient facility after TAA (16.6% vs. 13.4%), but this
was not significant (P = 0.36). Five Whites and four
Blacks died after TAA; mortality was higher in Blacks
compared with Whites (P = 0.02; Table 4). Additional
file 2 shows these outcomes by time period in more de-
tail. In general, the length of stay decreased and dis-
charge to an inpatient facility increased over time.
Discussion
To our knowledge, our study is the first to examine ra-
cial disparities in TAA utilization and outcomes in the
United States. We found important differences ines per 100,000 by race and gender















lculation of a P value; a frequency of 0 indicates that no TAA procedure was
trend from 1998 to 2011: White males, P <0.0001; Black males, P = 0.0031;
dicates the difference between the groups.
AB
Figure 2 Age-specific total ankle arthroplasty utilization rates per 100,000 for Whites and Blacks. (A) Age-specific rates for Whites.
Cochran Armitage test comparing total ankle arthroplasty (TAA) utilization in all years: age <50, P = 0.11; age 50 to 64, P <0.0001; age 65 to 79,
P <0.0001; age ≥80, P <0.0001. (B) Age-specific rates for Blacks. Cochran Armitage test comparing TAA utilization in all years: age <50, P = 0.07;
age 50 to 64, P = 0.053; age 65 to 79, P = 0.009; age ≥80, P = 0.0002.
Table 4 Unadjusted outcomes by race including all data
from 1998 to 2011
White (n = 12,122) Black (n = 488) P value
Length of stay >median 5,366 (44.3%) 258 (52.9%) 0.08
Discharge
Home 10,476 (86.6%) 403 (83.4%) 0.36
Inpatient facility 1,628 (13.4%) 80 (16.6%)
Mortality 5 (0.04%) 4 (0.9%) 0.02
Data presented as n (%).
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Whites undergoing TAA. The TAA utilization rates were
lower in Blacks compared with Whites for all years.
White–Black disparities in TAA utilization increased
over the 12-year period, from a twofold higher rate in
Whites compared with Blacks in 1998 to an almost four-
fold higher rate in 2011, significant both statistically and
clinically (absolute difference in rate increased 12-fold).
Blacks had a longer hospital stay and higher mortality
compared with Whites, but no differences in discharge
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from our study merit further discussion.
The TAA utilization rate was significantly lower in
Blacks compared with Whites in 1998 as well as 2011.
The absolute White–Black difference in TAA utilization
rate was 0.07 per 100,000 in 1998 and 0.84 per 100,000
in 2011 (a 12-fold higher difference) and the relative rate
was twofold in 1998 and fourfold in 2011. Racial dispar-
ities increased significantly, both statistically and in a
clinical meaningful way. Our time-trend analysis is the
first to indicate that there was clear evidence of widen-
ing racial disparity in TAA utilization over the 12-year
study period. Racial disparities with lower rates of knee
and hip arthroplasty utilization in Blacks, compared with
Whites, have been shown in studies using regional data
[38] and national Medicare data [18]. Our study ex-
tended these findings of the presence of racial disparities
to TAA populations. The increasing disparities in TAA
utilization should be very concerning, since this trend
was far worse than an absence of reduction of disparities
in the utilization over time for knee/hip arthroplasty, re-
ported previously [39,40]. Policy-makers should consider
the worsening racial disparities in TAA utilization rates
an important warning. This trend of worsening dispar-
ities is in the opposite direction to that recommended by
the 2012 Institute of Medicine report [6], which drew at-
tention to existing racial disparities in health care and
the need to reduce and eliminate disparities. We found
an increasing gap in TAA utilization between Blacks and
Whites over time. Our study findings of increasing dis-
parity indicate that policy-makers need to develop and im-
plement policies to eliminate these disparities, including
the widening gap in TAA utilization between Blacks and
Whites.
The lower arthroplasty utilization rates in Blacks could
not be explained by surgical appropriateness or disease
burden, since there are no significant racial differences
in proportions with at least moderately severe OA
deemed appropriate for arthroplasty [41]. Blacks have a
higher disease burden of arthritis than Whites [8-13].
Socioeconomic status differences explained only some
racial differences in arthroplasty utilization [42]. Blacks
have a higher fear of arthroplasty compared with Whites
[43]. Previous studies showed that Blacks presented with
worse preoperative hip and knee function at the time of
hip or knee arthroplasty than Whites [44] and had lon-
ger delays to presentation and higher body mass index
at the time of hip arthroplasty compared with Whites
[45]. This indicated a worse preoperative patient status in
Blacks undergoing arthroplasty, which is associated with
poorer postoperative pain and function outcomes [46].
Blacks were less willing than Whites to undergo total knee
or hip joint replacement surgery [47]. Future studies are
needed to explore whether patient preferences, health careaccess barriers, adequacy of social support/network and/
or other factors can explain these racial disparities. A bet-
ter understanding of racial disparities and factors associ-
ated with it will help the development of interventions
targeting these racial disparities in arthroplasty utilization.
With our findings in TAA, these findings may be particu-
larly relevant to Blacks undergoing TAA. Once effective
interventions can be developed, they can be implemented
to eliminate these racial disparities.
We found that Blacks undergoing TAA differed from
Whites regarding demographic and clinical characteris-
tics. Blacks undergoing TAA were younger than Whites,
had a higher proportion of females, had differences in
the underlying diagnosis (lower proportion had OA,
higher proportion had rheumatoid arthritis and other
diagnoses) and had higher comorbidity. Since the impact
of each of these characteristics (age, sex, diagnosis and
medical comorbidity) on TAA outcomes is not known at
this time, it is not possible to predict whether these fac-
tors positively or negatively impact the outcomes of
TAA in Blacks versus Whites. Future studies that can
examine the impact of these factors on outcomes can
help us better understand their contribution to differ-
ences in TAA outcomes or the lack thereof.
We found that a higher proportion of Blacks who
underwent TAA had hospital stay longer than the overall
median hospital stay compared with Whites, which al-
most reached significance (P = 0.056). Mortality after
TAA, although rare in both Blacks and Whites, was
higher in Blacks compared with Whites. These are novel
findings. In the absence of any previous studies, no com-
parisons could be made. This longer hospital stay in
Blacks compared with Whites might be due to a delayed
presentation [45], worse preoperative pain and function
[44], and worse function on performance tests [13] in
Blacks, all of which can delay post-arthroplasty recovery.
Our study showed that Blacks were also more likely to
undergo TAA at hospitals with the lowest annual volume
(<5 procedures/year) compared with Whites. This racial
difference in utilization of hospitals with lower volume
may have contributed to worse outcomes among Blacks
compared with Whites after TAA, including a longer
post-arthroplasty hospital stay and higher mortality in
Blacks. Racial differences in social support, higher comor-
bidity and higher rates of other risk factors for poor out-
comes and mortality might also have contributed. This
finding is similar to a recent finding by Cai and colleagues
that Blacks undergoing knee/hip arthroplasty were more
likely than Whites to be admitted to hospitals with higher
risk-adjusted postoperative rates of complications or mor-
tality [48]. Studies need to explore why minorities are
more likely to undergo arthroplasty at low-volume hospi-
tals, which are often associated with worse outcomes. The
practical implications of these findings are that Blacks
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garding the association of hospital volume and arthro-
plasty outcomes to make informed decisions.
Our study findings must be interpreted considering
the study limitations and strengths. The NIS treats each
hospital admission as an event, which would theoretic-
ally miss bilateral TAAs performed during a single
hospitalization. Bilateral TAA is rare, however, so this is
unlikely to have biased the estimates. The NIS does not
include federal facilities such as military and Veterans
Affairs hospitals. However, it is a nationally representa-
tive dataset and several studies using NIS data for knee,
shoulder and hip arthroplasty have been published
[49-52], supporting its generalizability. We used the en-
tire US population for calculating the rates, a method
that has been used in other studies from the NIS [53,54].
We used the ICD-9-CM for identifying TAA, similar to
the codes used in other arthroplasty studies, which have
been found to be accurate [55]. Another limitation of
these analyses is that the underlying diagnoses of OA/
rheumatoid arthritis/avascular necrosis and so forth may
or may not be joint specific; their accuracy and positive
predictive values have not been established and therefore
some misclassification is possible. Mortality differences
were based on very small numbers and therefore should
be interpreted with caution.Conclusions
This study found that the racial disparity in annual TAA
utilization increased from twofold in 1998 to fourfold in
2011 in the United States. Blacks also had a slightly lon-
ger hospital stay and higher mortality compared with
Whites. There were no racial differences in discharge
disposition. The persisting and perhaps worsening racial
disparities in TAA utilization and outcomes over a 13-
year study period should serve as a wake-up call for pa-
tients, surgeons and policy-makers. Further studies are
needed to investigate why the racial disparities in TAA
are worsening and to develop strategies for addressing
this problem. Policy-makers should implement policies
that can reduce this racial disparity gap in utilization
and outcomes of TAA.
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